ForsideLtd Balance Sheet Health
Financial Health criteria checks 3/6
ForsideLtd has a total shareholder equity of ¥2.1B and total debt of ¥661.0M, which brings its debt-to-equity ratio to 31.1%. Its total assets and total liabilities are ¥5.9B and ¥3.7B respectively. ForsideLtd's EBIT is ¥2.0M making its interest coverage ratio 1. It has cash and short-term investments of ¥2.1B.
Key information
31.1%
Debt to equity ratio
JP¥661.00m
Debt
Interest coverage ratio | 1x |
Cash | JP¥2.12b |
Equity | JP¥2.13b |
Total liabilities | JP¥3.74b |
Total assets | JP¥5.86b |
Recent financial health updates
Is ForsideLtd (TSE:2330) Using Too Much Debt?
May 12Is ForsideLtd (TYO:2330) Using Debt Sensibly?
Apr 24Is Forside (TYO:2330) A Risky Investment?
Jan 09Recent updates
Forside Co.,Ltd.'s (TSE:2330) 27% Share Price Plunge Could Signal Some Risk
Aug 23ForsideLtd (TSE:2330) Shareholders Will Want The ROCE Trajectory To Continue
Jul 15Forside Co.,Ltd. (TSE:2330) May Have Run Too Fast Too Soon With Recent 25% Price Plummet
Jun 08Is ForsideLtd (TSE:2330) Using Too Much Debt?
May 12Some Forside Co.,Ltd. (TSE:2330) Shareholders Look For Exit As Shares Take 32% Pounding
Apr 20We Like These Underlying Return On Capital Trends At ForsideLtd (TSE:2330)
Apr 11There's Reason For Concern Over Forside Co.,Ltd.'s (TSE:2330) Massive 407% Price Jump
Feb 26Is ForsideLtd (TYO:2330) Using Debt Sensibly?
Apr 24Is Forside (TYO:2330) A Risky Investment?
Jan 09Financial Position Analysis
Short Term Liabilities: 2330's short term assets (¥5.0B) exceed its short term liabilities (¥3.4B).
Long Term Liabilities: 2330's short term assets (¥5.0B) exceed its long term liabilities (¥368.0M).
Debt to Equity History and Analysis
Debt Level: 2330 has more cash than its total debt.
Reducing Debt: 2330's debt to equity ratio has increased from 28.2% to 31.1% over the past 5 years.
Debt Coverage: 2330's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 2330's interest payments on its debt are not well covered by EBIT (1x coverage).